In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumour suppressor.
Verge Genomics, the drug discovery startup we recently featured in our Top 5 Startups Disrupting Healthcare, has raised $32 million in Series A financing.
Personalised medicine has been a goal of researchers and doctors for a long time. Now, researchers have developed what they call a personalised Therapeutic Intervention Fingerprint (pTIF), for patients with neurological disease.
Researchers at Harvard Medical School have found further evidence that supports the notion that viruses could help cause the onset of Alzheimer’s disease; an idea that was once ridiculed by other sceptics and researchers.
One year after researchers published their work on a physiological test for autism, a follow-up study has confirmed its exceptional success in assessing whether a child is on the autism spectrum.
Scientists have discovered a “big bang” of Alzheimer’s disease — the precise point at which a healthy protein becomes toxic but has not yet formed deadly tangles in the brain.
Scientists have identified a molecular pathway that allows females to be more resilient to maternal stress than males which might explain why males are more at risk than females for neurodevelopmental disorders.
Researchers have developed a type of personalised machine learning that helps robots estimate the engagement and interest of each a child during autism therapy, using data that are unique to that child.
Psychiatric disorders share many genetic variants, while neurological disorders appear more distinct, according to a new study from the Brainstorm Consortium.
Digital health devices have become invaluable tools for improving human health. However, could a pill carrying an inbuilt sensor dehumanize patients, reducing them to a digital readout?